603392 万泰生物
已收盘 07-22 15:00:00
资讯
新帖
简况
万泰生物最新公告:全资子公司与GSK合作协议终止
证券之星 · 07-22 17:40
万泰生物最新公告:全资子公司与GSK合作协议终止
万泰生物(603392.SH):与GSK关于新一代宫颈癌疫苗的开发和商业化的合作协议终止
智通财经 · 07-22 17:32
万泰生物(603392.SH):与GSK关于新一代宫颈癌疫苗的开发和商业化的合作协议终止
万泰生物(603392.SH):全资子公司与GSK合作协议终止
格隆汇资讯 · 07-22 17:24
万泰生物(603392.SH):全资子公司与GSK合作协议终止
万泰生物07月19日主力资金流出2601万元 连续3日减仓
自选股智能写手 · 07-19
万泰生物07月19日主力资金流出2601万元 连续3日减仓
7月17日万泰生物涨5.23%,招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 07-17
7月17日万泰生物涨5.23%,招商国证生物医药指数(LOF)C基金重仓该股
国内制药企业迎来新一轮创新产品周期,创新药ETF(159992)实时成交额突破2.08亿元,百奥泰、万泰生物、迪哲医药-U领涨。
和讯网 · 07-17
国内制药企业迎来新一轮创新产品周期,创新药ETF(159992)实时成交额突破2.08亿元,百奥泰、万泰生物、迪哲医药-U领涨。
猴痘概念盘中拉升,万泰生物涨5.34%
自选股智能写手 · 07-17
猴痘概念盘中拉升,万泰生物涨5.34%
生物疫苗概念盘中拉升,万泰生物涨5.54%
自选股智能写手 · 07-17
生物疫苗概念盘中拉升,万泰生物涨5.54%
疫苗龙头企业竞争优势凸显,疫苗生物ETF(561710)涨超2.0%,万泰生物领涨
和讯网 · 07-17
疫苗龙头企业竞争优势凸显,疫苗生物ETF(561710)涨超2.0%,万泰生物领涨
万泰生物创3月新高 获北向资金增持34.03万股
智选洞察 · 07-17
万泰生物创3月新高 获北向资金增持34.03万股
生物制品行业盘中拉升,万泰生物涨4.53%
自选股智能写手 · 07-17
生物制品行业盘中拉升,万泰生物涨4.53%
万泰生物: 面对新厂家HPV疫苗的陆续上市,公司二价HPV疫苗的国内市场确实承受了不小的压力
证券之星 · 07-16
万泰生物: 面对新厂家HPV疫苗的陆续上市,公司二价HPV疫苗的国内市场确实承受了不小的压力
万泰生物:公司的鼻喷新冠疫苗有一定储备,具有生产能力,可根据需要迅速投入生产
每日经济新闻 · 07-16
万泰生物:公司的鼻喷新冠疫苗有一定储备,具有生产能力,可根据需要迅速投入生产
万泰生物:“万泰沧海新产品评价实验室建设项目”主要用于公司在研疫苗产品的早期评价实验研究工作
每日经济新闻 · 07-16
万泰生物:“万泰沧海新产品评价实验室建设项目”主要用于公司在研疫苗产品的早期评价实验研究工作
万泰生物新提交6件商标注册申请
证券之星 · 07-16
万泰生物新提交6件商标注册申请
万泰生物创1月新高 1家券商给予增持建议
智选洞察 · 07-15
万泰生物创1月新高 1家券商给予增持建议
万泰生物07月12日主力资金流出332万元 连续3日减仓
自选股智能写手 · 07-12
万泰生物07月12日主力资金流出332万元 连续3日减仓
北向资金7月11日净买入万泰生物12.36万股 连续3日增持
自选股智能写手 · 07-12
北向资金7月11日净买入万泰生物12.36万股 连续3日增持
万泰生物最新公告:预计上半年净利同比减少85.90%到82.96%
证券之星 · 07-10
万泰生物最新公告:预计上半年净利同比减少85.90%到82.96%
万泰生物(603392.SH)发预减 疫苗板块收入下降 半年度净利润大跌82.96%至85.90%
智通财经 · 07-10
万泰生物(603392.SH)发预减 疫苗板块收入下降 半年度净利润大跌82.96%至85.90%
公司概况
公司名称:
北京万泰生物药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-04-29
主营业务:
北京万泰生物药业股份有限公司是从事体外诊断试剂、自动化检测设备、疫苗研发生产及销售的高新技术企业,其主要产品有疫苗、免疫诊断试剂、生化试剂、质控品、活性原料。公司获得国家企业技术中心、国家技术创新示范企业、国家地方联合工程实验室、国家知识产权优势企业、博士后科研工作站等95项省级及国家级荣誉称号;公司研发产品获得国家科学技术进步奖二等奖、国家技术发明奖二等奖、北京市科学技术一等奖、亚洲生物技术最佳创新奖及中国专利金奖等30项奖励。
发行价格:
8.75
{"stockData":{"symbol":"603392","market":"SH","secType":"STK","nameCN":"万泰生物","latestPrice":73.84,"timestamp":1721631600000,"preClose":74.22,"halted":0,"volume":3206898,"delay":0,"floatShares":1268000000,"shares":1268000000,"eps":0.1014,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.38,"latestTime":"07-22 15:00:00","open":74.28,"high":74.5,"low":73.06,"amount":237000000,"amplitude":0.0194,"askPrice":73.88,"askSize":10,"bidPrice":73.84,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.1014,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":74.22,"symbolType":"stock","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":81.64,"lowLimit":66.8,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1268206999,"pbRate":7.31,"roa":"--","roe":"0.99%","epsLYR":0.99,"committee":0.205379,"marketValue":93644000000,"floatMarketCap":93644000000,"peRate":728.205108,"changeRate":-0.0051,"turnoverRate":0.0025,"status":1},"requestUrl":"/m/hq/s/603392/wiki","defaultTab":"wiki","newsList":[{"id":"2453754027","title":"万泰生物最新公告:全资子公司与GSK合作协议终止","url":"https://stock-news.laohu8.com/highlight/detail?id=2453754027","media":"证券之星","labels":["Company Corporation"],"top":-1,"share":"https://www.laohu8.com/m/news/2453754027?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:40","pubTimestamp":1721641223,"startTime":"0","endTime":"0","summary":"万泰生物公告,全资子公司万泰沧海与GSK签署了合作协议终止函,决定不再继续新一代宫颈癌疫苗HPV9-AS04候选疫苗的开发和商业化合作。《合作协议》终止后万泰沧海将不再会收到《合作协议》项下约定的其他里程碑款及销售提成。《合作协议》终止的后续工作不会产生重大费用支出,亦不会产生重大资产减值。目前万泰沧海与厦门大学合作研发的九价HPV疫苗的临床申报工作仍在有序进行中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200024215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603392","LU1981816686.USD","BK0239","BK1200","BK1589","WNW"],"gpt_icon":1},{"id":"2453754573","title":"万泰生物(603392.SH):与GSK关于新一代宫颈癌疫苗的开发和商业化的合作协议终止","url":"https://stock-news.laohu8.com/highlight/detail?id=2453754573","media":"智通财经","labels":["Company Corporation"],"top":-1,"share":"https://www.laohu8.com/m/news/2453754573?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:32","pubTimestamp":1721640761,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万泰生物 公告,2019年9月6日,公司全资子公司厦门万泰沧海生物技术有限公司与葛兰素史克生物有限公司签署了《关于新一代宫颈癌疫苗的开发和商业化的合作协议》。《合作协议》约定双方基于万泰沧海的大肠杆菌原核表达疫苗抗原技术和GSK的佐剂技术合作开发新一代宫颈癌疫苗。经友好协商,双方决定不再继续《合作协议》项下的HPV9-AS04候选疫苗的开发和商业化合作,并于2024年7月20日签订《合作协议》终止函。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4007","GSK","GSK.UK","LU1829250122.USD","BK4588","603392","BK4532","LU1981816686.USD","BK1200","BK0239","BK1589","159646"],"gpt_icon":1},{"id":"2453175493","title":"万泰生物(603392.SH):全资子公司与GSK合作协议终止","url":"https://stock-news.laohu8.com/highlight/detail?id=2453175493","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453175493?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:24","pubTimestamp":1721640294,"startTime":"0","endTime":"0","summary":"格隆汇7月22日丨万泰生物公布,经友好协商,双方决定不再继续《合作协议》项下的HPV9-AS04候选疫苗的开发和商业化合作,并于2024年7月20日签订《合作协议》终止函。《合作协议》终止的后续工作不会产生重大费用支出,亦不会产生重大资产减值。目前万泰沧海与厦门大学合作研发的九价HPV疫苗的临床申报工作仍在有序进行中,不会受到《合作协议》终止的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221725089ede91ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221725089ede91ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2452432084","title":"万泰生物07月19日主力资金流出2601万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2452432084","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452432084?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:19","pubTimestamp":1721373560,"startTime":"0","endTime":"0","summary":"07月19日, 万泰生物股价涨1.13%,报收74.22元,成交金额3.17亿元,换手率0.34%,振幅2.49%,量比0.80。万泰生物今日主力资金净流出2601万元,连续3日净流出,上一交易日主力净流出3052万元,今日环比减少14.78%。该股近5个交易日上涨12.42%,主力资金累计净流出5738万元;近20日主力资金累计净流出1.40亿元,其中净流出天数为16日。净流出前三个股分别为万泰生物、上海莱士、智飞生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071915322695db486d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071915322695db486d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2452827721","title":"7月17日万泰生物涨5.23%,招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452827721","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452827721?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:20","pubTimestamp":1721204443,"startTime":"0","endTime":"0","summary":"证券之星消息,7月17日万泰生物涨5.23%创60日新高,收盘报73.7元,换手率0.69%,成交量8.73万手,成交额6.41亿元。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共34家,其中持有数量最多的公募基金为招商国证生物医药指数C。招商国证生物医药指数C目前规模为18.51亿元,最新净值0.3518,较上一交易日上涨0.86%,近一年下跌28.2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700032557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK1589","399441","LU1981816686.USD","603392","BK1200","BK0239"],"gpt_icon":1},{"id":"2452018608","title":"国内制药企业迎来新一轮创新产品周期,创新药ETF(159992)实时成交额突破2.08亿元,百奥泰、万泰生物、迪哲医药-U领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452018608","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452018608?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:29","pubTimestamp":1721194186,"startTime":"0","endTime":"0","summary":"盘面上,百奥泰领涨,万泰生物、迪哲医药-U跟涨,创新药ETF市场热度较高,过去10个交易日日均成交额达到2.22亿元。广发证券表示,国内制药企业将迎来新一轮创新产品周期。2023年CDE承办新药临床开发项目超过760项,新药首次上市申报达到110项。据此操作,风险自担。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071715304195cd3880&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071715304195cd3880&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239","603392","515120","688192","159992"],"gpt_icon":0},{"id":"2452968901","title":"猴痘概念盘中拉升,万泰生物涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452968901","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452968901?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:03","pubTimestamp":1721192634,"startTime":"0","endTime":"0","summary":"07月17日,猴痘概念盘中拉升,截至13点03分,猴痘概念整体指数上涨1.01%,报756.100点。从个股上来看,该概念的成分股中,万泰生物涨5.34%,新产业、百克生物、安图生物涨幅居前。从资金上来看,截止发稿,猴痘概念主力净流入为-4846.67万,其中新产业受到资金热捧,主力净流入1285.57万;拉长时间线来看,该板块近20日主力资金净流入-10.24亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717130354af92b2c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717130354af92b2c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2452890359","title":"生物疫苗概念盘中拉升,万泰生物涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452890359","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452890359?lang=zh_cn&edition=full","pubTime":"2024-07-17 11:28","pubTimestamp":1721186893,"startTime":"0","endTime":"0","summary":"07月17日,生物疫苗概念盘中拉升,截至11点28分,生物疫苗概念整体指数上涨1.00%,报1699.290点。从个股上来看,该概念的成分股中,万泰生物涨5.54%,智飞生物、昭衍新药、沃森生物涨幅居前。从资金上来看,截止发稿,生物疫苗概念主力净流入为7511.49万,其中昭衍新药受到资金热捧,主力净流入1897.57万;拉长时间线来看,该板块近20日主力资金净流入-19.34亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717112813aefa0c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717112813aefa0c4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603127","06127","603392","159657"],"gpt_icon":0},{"id":"2452908982","title":"疫苗龙头企业竞争优势凸显,疫苗生物ETF(561710)涨超2.0%,万泰生物领涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2452908982","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452908982?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:56","pubTimestamp":1721185006,"startTime":"0","endTime":"0","summary":"截至2024年7月17日 10:45,中证疫苗与生物技术指数强势上涨1.86%,成分股万泰生物上涨6.42%,迪哲医药上涨4.99%,百奥泰上涨4.54%,百济神州,百克生物等个股跟涨。疫苗生物ETF上涨2.06%,最新价报0.55元。万泰生物近期发布2024年半年度业绩预减公告。在新型疫苗方面,又一mRNARSV疫苗即石药集团研发的呼吸道合胞病毒疫苗临床试验获批。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171117219f5a9eb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171117219f5a9eb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["561710","159645","BK0239","603392"],"gpt_icon":0},{"id":"2452972825","title":"万泰生物创3月新高 获北向资金增持34.03万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452972825","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452972825?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:24","pubTimestamp":1721183063,"startTime":"0","endTime":"0","summary":"07月17日,万泰生物股价大幅上涨,截至10点24分,万泰生物上涨5.05%,报73.58元/股,创近3月新高,成交3.04亿元,换手率0.33%,振幅5.67%。北向资金方面,万泰生物07月16日获得北向资金增持34.03万股,截至07月16日,北向资金当前共持有万泰生物1878.56万股,市值13.82亿元,持股占流通股比为1.48%。最新财报显示,今年一季报,万泰生物实现营业收入7.53亿元,同比减少73.93%,净利润为1.26亿元,同比减少89.90%,基本每股收益为0.10元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717102442af92ae49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717102442af92ae49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2452728269","title":"生物制品行业盘中拉升,万泰生物涨4.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452728269","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452728269?lang=zh_cn&edition=full","pubTime":"2024-07-17 10:20","pubTimestamp":1721182821,"startTime":"0","endTime":"0","summary":"07月17日,生物制品行业盘中拉升,截至10点20分,生物制品行业整体指数上涨0.50%,报5863.130点。从个股上来看,该行业的成分股中,万泰生物涨4.53%,百克生物、百奥泰、义翘神州涨幅居前。从资金上来看,截止发稿,生物制品行业主力净流入为-740.08万,其中沃森生物受到资金热捧,主力净流入1080.61万;拉长时间线来看,该板块近20日主力资金净流入-28.27亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717102021941f7abd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717102021941f7abd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2451961549","title":"万泰生物:\n面对新厂家HPV疫苗的陆续上市,公司二价HPV疫苗的国内市场确实承受了不小的压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2451961549","media":"证券之星","labels":["Product Release"],"top":-1,"share":"https://www.laohu8.com/m/news/2451961549?lang=zh_cn&edition=full","pubTime":"2024-07-16 18:04","pubTimestamp":1721124263,"startTime":"0","endTime":"0","summary":"投资者:7月4日,中生成都所自研4价HPV疫苗申报上市,后续获批,是否会对公司现有二价HPV疫苗造成毁灭性打击?面对新厂家HPV疫苗的陆续上市,公司二价HPV疫苗的国内市场确实承受了不小的压力。市场方面,公司在保障国内市场供应的同时,积极开拓国际市场,已获得十余个国家的上市许可,今年将围绕全球尚未将HPV疫苗纳入国家计划免疫规划的国家开展市场拓展和销售工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600036466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","BK0239","603392","BK1589","159646","BK1200"],"gpt_icon":1},{"id":"2451961520","title":"万泰生物:公司的鼻喷新冠疫苗有一定储备,具有生产能力,可根据需要迅速投入生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2451961520","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451961520?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:43","pubTimestamp":1721123007,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:新冠疫苗7.15日后自费了,公司的鼻喷新冠疫苗是否会参与?目前是否还有存货?后续是否会重启产线?万泰生物(603392.SH)7月16日在投资者互动平台表示,公司的鼻喷新冠疫苗有一定储备,具有生产能力,可根据需要迅速投入生产。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161743519f55306b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161743519f55306b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","BK0239","603392"],"gpt_icon":0},{"id":"2451923968","title":"万泰生物:“万泰沧海新产品评价实验室建设项目”主要用于公司在研疫苗产品的早期评价实验研究工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2451923968","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451923968?lang=zh_cn&edition=full","pubTime":"2024-07-16 16:53","pubTimestamp":1721120039,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:根据公开信息,万泰沧海于2024年6月28日登记了一个“新产品评价实验室建设项目”,拟于今年7月开工,12月建成,请问下这个项目主要是用于什么疫苗制造呢?万泰生物(603392.SH)7月16日在投资者互动平台表示,“万泰沧海新产品评价实验室建设项目”主要用于公司在研疫苗产品的早期评价实验研究工作。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071616541295c65359&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071616541295c65359&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","159646","BK0239"],"gpt_icon":0},{"id":"2451437931","title":"万泰生物新提交6件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2451437931","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451437931?lang=zh_cn&edition=full","pubTime":"2024-07-16 12:44","pubTimestamp":1721105060,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日北京万泰生物药业股份有限公司新提交6件商标注册申请。商标申请详情如下:今年以来北京万泰生物药业股份有限公司新申请注册商标12件,截止目前公司共持有注册商标114件,另有13件商标尚在注册申请中。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600023860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","BK0239","603392","BK1589","09633","BK1200"],"gpt_icon":0},{"id":"2451710695","title":"万泰生物创1月新高 1家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2451710695","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451710695?lang=zh_cn&edition=full","pubTime":"2024-07-15 13:59","pubTimestamp":1721023172,"startTime":"0","endTime":"0","summary":"07月15日,万泰生物股价大幅上涨,截至13点59分,万泰生物上涨5.15%,报69.42元/股,创近1月新高,成交2.37亿元,换手率0.28%,振幅6.57%。资金动向截止发稿,万泰生物获得主力净流出176万元,其中超大单流出533万元,大单流入358万元。北向资金方面,万泰生物07月12日获得北向资金增持1.16万股,连续4日增持,截至07月12日,北向资金当前共持有万泰生物1846.98万股,市值12.82亿元,持股占流通股比为1.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715135940af925055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715135940af925055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2450615374","title":"万泰生物07月12日主力资金流出332万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450615374","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450615374?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:17","pubTimestamp":1720768651,"startTime":"0","endTime":"0","summary":"07月12日, 万泰生物股价涨0.11%,报收66.02元,成交金额1.12亿元,换手率0.13%,振幅1.32%,量比0.89。万泰生物今日主力资金净流出332万元,连续3日净流出,上一交易日主力净流出878万元,今日环比减少62.19%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为60.00%,平均跌幅为2.08%。该股近5个交易日上涨0.11%,主力资金累计净流出2651万元;近20日主力资金累计净流出1.11亿元,其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121520229f3a105f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121520229f3a105f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2450342185","title":"北向资金7月11日净买入万泰生物12.36万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450342185","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450342185?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:30","pubTimestamp":1720747832,"startTime":"0","endTime":"0","summary":"7月11日, 北向资金增持万泰生物12.36万股,连续3日增持。截止当日收盘,沪股通共持有万泰生物1845.82万股,占流通股1.45%。沪股通增持金额前五个股分别为贵州茅台、中国核电、紫金矿业、中国中免、长江电力。万泰生物近5个交易日上涨1.31%,沪股通累计增持47.20万股;近20个交易日下跌3.13%,沪股通累计增持112.71万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071209343195a9f4bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071209343195a9f4bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2450850980","title":"万泰生物最新公告:预计上半年净利同比减少85.90%到82.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450850980","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450850980?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:31","pubTimestamp":1720600274,"startTime":"0","endTime":"0","summary":"万泰生物公告,预计2024年半年度实现归属于母公司所有者的净利润为2.4亿元到2.9亿元,同比减少85.90%到82.96%。报告期内,疫苗板块主要产品二价HPV疫苗持续受九价HPV疫苗扩龄以及市场竞争、降库存等因素影响,销售收入及利润较去年同期回落。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000033895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603392","LU1981816686.USD","BK1589","09633","BK0239","BK1200"],"gpt_icon":0},{"id":"2450850792","title":"万泰生物(603392.SH)发预减 疫苗板块收入下降 半年度净利润大跌82.96%至85.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450850792","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450850792?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:28","pubTimestamp":1720600087,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万泰生物 披露2024年半年度业绩预减公告,该公司预计报告期归属于母公司所有者的净利润为2.4亿元到2.9亿元,同比减少85.90%到82.96%。报告期内,预计公司2024年第二季度营业收入为5.5亿元到6.8亿元,较去年同比减少约56.93%到46.75%,已与一季度降幅有所收窄。报告期内,疫苗板块主要产品二价HPV疫苗持续受九价HPV疫苗扩龄以及市场竞争、降库存等因素影响,销售收入及利润较去年同期回落。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09633","159646","603392"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-04-29","address":"北京市昌平区科学园路31号","stockEarnings":[{"period":"1week","weight":0.0748},{"period":"1month","weight":0.1176},{"period":"3month","weight":0.1234},{"period":"6month","weight":0.1966},{"period":"1year","weight":0.1104},{"period":"ytd","weight":-0.0126}],"companyName":"北京万泰生物药业股份有限公司","boardCode":"AI0027","perCapita":"30689股","boardName":"医药制造业","registeredCapital":"126820万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 北京万泰生物药业股份有限公司是从事体外诊断试剂、自动化检测设备、疫苗研发生产及销售的高新技术企业,其主要产品有疫苗、免疫诊断试剂、生化试剂、质控品、活性原料。公司获得国家企业技术中心、国家技术创新示范企业、国家地方联合工程实验室、国家知识产权优势企业、博士后科研工作站等95项省级及国家级荣誉称号;公司研发产品获得国家科学技术进步奖二等奖、国家技术发明奖二等奖、北京市科学技术一等奖、亚洲生物技术最佳创新奖及中国专利金奖等30项奖励。","serverTime":1721676339142,"listedPrice":8.75,"stockholders":"41324人(较上一季度减少15.73%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万泰生物,603392,万泰生物股票,万泰生物股票老虎,万泰生物股票老虎国际,万泰生物行情,万泰生物股票行情,万泰生物股价,万泰生物股市,万泰生物股票价格,万泰生物股票交易,万泰生物股票购买,万泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}